Johnson ML, Cho BC, Luft A, Alatorre-Alexander J, et al. Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study. J Clin Oncol 2022 Nov 3:JCO2200975. doi: 10.1200/JCO.22.00975.
PMID: 36327426